Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
about
The role of NKT cells in tumor immunityHow do natural killer T cells help B cells?Turned on by danger: activation of CD1d-restricted invariant natural killer T cellsThe regulatory role of invariant NKT cells in tumor immunityStructural Evaluation of Potent NKT Cell Agonists: Implications for Design of Novel Stimulatory LigandsThe Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding modeStructural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory PropertiesLinking inflammation to natural killer T cell activation.Stimulation of natural killer T cells by glycolipidsΑ-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agentsThe stimulating adventure of KRN 7000.T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoireMouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.Presentation of lipid antigens by CD1 glycoproteins.Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.Identification of self-lipids presented by CD1c and CD1d proteins.The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsImpact of sugar stereochemistry on natural killer T cell stimulation by bacterial glycolipids.Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.Glycolipid ligands of invariant natural killer T cells as vaccine adjuvantsSaposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.Dendritic cell-based cancer immunotherapies.Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.The cellular and biochemical rules of lipid antigen presentation.Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells.Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.Selective Conditions Are Required for the Induction of Invariant NKT Cell Hyporesponsiveness by Antigenic Stimulation.Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine productionNon-glycosidic compounds can stimulate both human and mouse iNKT cells.Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells.CD1: From Molecules to Diseases.Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.The synthesis and in vivo evaluation of 2',2'-difluoro KRN7000.Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity.
P2860
Q24648939-404011DF-E6AC-4929-96BD-7D359AFB6059Q24650966-D262EFCD-18DB-4DCD-B152-7F4F55535823Q26825059-BFF9390C-B565-4332-BB11-C86A404D170CQ27023425-6B3A1EF8-E2C2-4FA8-8FEB-B42DDCBA61A7Q27657337-EA112A20-73A2-4FEC-A5B6-5CD07F12379FQ27664892-9C474E80-A014-47B6-8BA5-BBD09D2986CAQ27677017-DD40E937-229E-4013-B6EA-DA45298ED9A7Q33512902-F26B3EA3-952D-4AA5-BC33-3E43B50027F6Q33599059-853EE38D-683B-43AE-AD33-D42268FC8AB2Q33778356-71DB4386-AAA8-4164-85B4-665599F87970Q33843406-3BDD3F97-5165-43DA-8FB3-C9663804E9CDQ34245603-9744D741-C479-48E9-84EA-0171DC0D4C6DQ34519826-68119729-54A0-4D1B-91E7-DC68A3D56CAAQ34987421-2B198761-C91E-4EBF-B411-4F3FB8E7BEC9Q35195374-87541CA4-1D96-4C8B-929F-4F1D5F10A8EFQ35424025-960AB4E2-59B3-4987-91C4-0AAEF93BB440Q35600087-AC403DFC-CBB4-41F9-AB87-FB2CD43FD485Q35841349-A4D79D57-1F68-4EF3-B861-41CC7580F8A9Q36702144-6D49A4D5-899D-418C-8491-6D10FC9A57BCQ37187603-83F5EC20-DE47-481D-949E-20DC9AE747C3Q37377504-83E523F7-BA0C-42A9-AF02-64219A998B57Q37458940-67CAB884-1485-4BBF-84C8-9C522E3F4D2EQ37500014-2B13AE2D-02B0-4081-B6E8-0D835C7AFCC0Q37548658-EF4E5E74-53C6-4752-9C7A-EA472FAE9090Q37591431-793F1B59-F131-4DC7-AB78-5BB4701B4209Q37657355-0F4B81DD-6844-4A0E-A8C2-34E9FDA4DA75Q38050484-1455209B-AD9C-4065-A461-D9362212E7F4Q39325800-E8CC6753-68EF-4C11-8663-0A3A48458A17Q39843991-8A175EDF-DA9A-4CD4-B7EE-D0189AE2972DQ39892288-E10D5D95-87EA-433F-BC83-13EEE5A28F65Q39955940-C67DB485-E61C-4603-BE3B-F955896B7127Q40556221-3D098784-06D8-4BB0-B6A3-B5FA1E469695Q41841063-427E7B8C-0DBD-4D5C-9B01-4D0210D18DD6Q42257577-831795D9-313F-45EB-85D1-3C8459A1E10FQ42608724-CB24FBE3-D840-47B3-982A-97144077A2D1Q42920496-12DD865A-C7D7-4AF8-A005-564C68E30643Q47111204-ED031468-ED58-4366-A69D-F6EA3A280ED6Q50075685-B49F3437-8B9D-426B-AFCB-A197E59B539EQ53050285-5B1D2CA1-0799-412A-A912-E1D0A195E41AQ55280646-676B3B5D-CA10-4DDE-A3CC-2064FC4C2B19
P2860
Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cutting edge: nonglycosidic CD ...... nd murine invariant NKT cells.
@en
Cutting edge: nonglycosidic CD ...... nd murine invariant NKT cells.
@nl
type
label
Cutting edge: nonglycosidic CD ...... nd murine invariant NKT cells.
@en
Cutting edge: nonglycosidic CD ...... nd murine invariant NKT cells.
@nl
prefLabel
Cutting edge: nonglycosidic CD ...... nd murine invariant NKT cells.
@en
Cutting edge: nonglycosidic CD ...... nd murine invariant NKT cells.
@nl
P2093
P50
P1476
Cutting edge: nonglycosidic CD ...... nd murine invariant NKT cells.
@en
P2093
B Gopal Reddy
Gerd Ritter
Gurdyal S Besra
James Brown
Paolo Polzella
Richard R Schmidt
S Hajar Masri
P304
P356
10.4049/JIMMUNOL.180.10.6452
P407
P577
2008-05-01T00:00:00Z